| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.29 | 7e-08 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.25 | 0.004 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0002 |